EA
CELG

Emerald Acquisition’s Celgene Corp CELG Stock Holding History

Emerald Acquisition’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$42M Sell
401,791
-196,476
-33% -$21.3M 0.08% 291
2016
Q2 		$59M Buy
+598,267
New +$61.9M 0.1% 225

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Acquisition's CELG Position: Q3 2016 in Review

Emerald Acquisition reduced its Celgene Corp (CELG) stake by 33% in Q3 2016, selling an estimated $21.3M and leaving 401,791 shares worth $42M. The position accounts for 0.08% of the portfolio, ranked #291.

Emerald Acquisition first reported a position in CELG in Q2 2016 and has held it in 2 quarters since. The position peaked at $59M in Q2 2016. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Emerald Acquisition held 401,791 shares of Celgene Corp worth $42M as of Q3 2016.
  • Emerald Acquisition sold 196,476 Celgene Corp shares in Q3 2016, an estimated $21.3M.
  • Celgene Corp made up 0.08% of Emerald Acquisition's portfolio in Q3 2016, its #291 holding.
  • Emerald Acquisition first reported a position in Celgene Corp in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Celgene Corp position peaked at $59M in Q2 2016.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.